Total Payments
$10,186
2024 Payments
$1,655
Companies
37
Transactions
624
Medicare Patients
4,694
Medicare Billing
$528,425
Payment Breakdown by Category
Food & Beverage$10,180 (99.9%)
Education$6.61 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,180 | 623 | 99.9% |
| Education | $6.61 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,713 | 228 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,070 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $682.05 | 45 | $0 (2024) |
| Celgene Corporation | $557.00 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $390.39 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $380.65 | 29 | $0 (2024) |
| QOL Medical, LLC | $279.68 | 12 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $245.86 | 16 | $0 (2024) |
| GENZYME CORPORATION | $238.46 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $231.33 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,655 | 88 | ABBVIE INC. ($538.19) |
| 2023 | $2,118 | 120 | AbbVie Inc. ($736.03) |
| 2022 | $1,602 | 85 | ABBVIE INC. ($734.08) |
| 2021 | $1,071 | 61 | AbbVie Inc. ($240.21) |
| 2020 | $300.47 | 20 | AbbVie Inc. ($178.50) |
| 2019 | $1,051 | 72 | AbbVie, Inc. ($349.04) |
| 2018 | $1,236 | 93 | AbbVie, Inc. ($476.42) |
| 2017 | $1,152 | 85 | AbbVie, Inc. ($460.08) |
All Payment Transactions
624 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Gastroenterology | ||||||
| 11/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Immunology | ||||||
| 10/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Gastroenterology | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,028 | 1,088 | $530,822 | $114,296 |
| 2022 | 16 | 1,171 | 1,310 | $605,982 | $130,736 |
| 2021 | 17 | 1,245 | 1,376 | $635,067 | $143,002 |
| 2020 | 17 | 1,250 | 1,406 | $634,889 | $140,391 |
Total Patients
4,694
Total Services
5,180
Medicare Billing
$528,425
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 174 | $47,850 | $16,213 | 33.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 71 | 71 | $85,166 | $14,882 | 17.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 155 | 162 | $105,300 | $13,589 | 12.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 66 | 67 | $53,300 | $12,349 | 23.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 79 | 80 | $68,000 | $10,073 | 14.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 90 | $27,000 | $9,188 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $24,800 | $8,034 | 32.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 27 | 27 | $21,000 | $4,831 | 23.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 75 | $14,956 | $4,764 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 66 | $13,200 | $4,320 | 32.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 36 | $21,250 | $3,093 | 14.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $18,100 | $3,068 | 17.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $8,400 | $2,729 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 22 | $5,500 | $2,120 | 38.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 52 | $5,200 | $2,111 | 40.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 28 | $4,200 | $1,078 | 25.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $4,000 | $1,036 | 25.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $3,600 | $816.36 | 22.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 118 | 119 | $47,600 | $18,347 | 38.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 201 | 203 | $131,950 | $17,266 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 162 | $44,550 | $14,705 | 33.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 59 | 61 | $73,026 | $11,684 | 16.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 61 | 61 | $48,500 | $11,343 | 23.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 80 | 82 | $69,700 | $10,269 | 14.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 108 | 177 | $33,156 | $9,862 | 29.7% |
About Dr. Kevin Comar, MD
Dr. Kevin Comar, MD is a Gastroenterology healthcare provider based in St Johns, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184832909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Comar, MD has received a total of $10,186 in payments from pharmaceutical and medical device companies, with $1,655 received in 2024. These payments were reported across 624 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,180).
As a Medicare-enrolled provider, Comar has provided services to 4,694 Medicare beneficiaries, totaling 5,180 services with total Medicare billing of $528,425. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location St Johns, FL
- Active Since 05/18/2007
- Last Updated 11/08/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1184832909
Products in Payments
- Humira (Biological) $1,050
- XIFAXAN (Drug) $794.54
- RINVOQ (Biological) $711.10
- LINZESS (Drug) $680.38
- HUMIRA (Biological) $491.68
- ZEPOSIA (Drug) $474.48
- DUPIXENT (Biological) $469.79
- STELARA (Biological) $457.05
- SKYRIZI (Biological) $444.91
- DIFICID (Drug) $322.54
- Cimzia (Drug) $225.88
- XELJANZ (Drug) $209.74
- VIBERZI (Drug) $191.45
- OMVOH (Drug) $169.99
- TRULANCE (Drug) $157.37
- GATTEX (Drug) $155.29
- Linzess (Drug) $151.33
- EVIS EXERA lll COLONOVIDEOSCOPE (Device) $149.11
- SUCRAID (Drug) $145.94
- Entyvio (Biological) $139.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in St Johns
Dr. Bradford Joseph, Md, MD
Gastroenterology — Payments: $15,788
Gastroenterology $15,788
Dr. Donevan Westerveld, M.d, M.D
Gastroenterology — Payments: $5,180
Gastroenterology $5,180
Dr. Ronald Racho, D.o, D.O
Gastroenterology — Payments: $4,497
Gastroenterology $4,497
Buffie Reid, Md, MD
Gastroenterology — Payments: $3,730
Gastroenterology $3,730
Emily Poland, Do, DO
Gastroenterology — Payments: $3,664
Gastroenterology $3,664
Christopher Navas, Md, MD
Gastroenterology — Payments: $2,016
Gastroenterology $2,016